Application of serum C-reactive protein in comparison with βeta-2-microglobulin in patient with multiple myeloma

Application of serum C-reactive protein in comparison with βeta-2-microglobulin in patient with multiple myeloma

Background: Multiple myeloma (MM) is a clonal proliferation of malignant plasma cells in the bone marrow that produced monoclonal protein, and associated with different organ dysfunction. β2 Microglubulin is a known prognostic marker while CRP is proposed to be of equivalent significance. Objective:...

Full description

Bibliographic Details
Main Authors: Sammer A Najjar, Waseem F Al Tameemi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Iraqi Journal of Hematology
Subjects:
C-reactive protein
multiple myeloma
plasma cell disorders
prognosis
βeta-2-microglobulin
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2017;volume=6;issue=1;spage=6;epage=11;aulast=Najjar

Internet

http://www.ijhonline.org/article.asp?issn=2072-8069;year=2017;volume=6;issue=1;spage=6;epage=11;aulast=Najjar

Similar Items